Treatment with biologic DMARDs vs standard therapy improved clinical response rates and flare outcomes among patients with polyarticular JIA.
Biologic vs conventional DMARDs may offer cardioprotective benefits among patients with PsA, though an increased risk for infection requires vigilance.
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...
MedPage Today on MSN
Not All Drugs Approved for Rheumatoid Arthritis Are Equal for Pain Relief
Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...
Objectives To examine the association between social determinants of health (SDH) and outcomes in systemic lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback